Clinical Trial Update: CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating CT-011 and a p53 genetic vaccine for advanced solid tumors was withdrawn; the study encompassed breast cancer, colon cancer, pancreat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colon Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Sarcoma

Drugs mentioned

• CT-011
• p53 genetic vaccine

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer, Colon Cancer | Phase 1 | Status: WITHDRAWN